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Brominated flame retardants are a novel
group of global environmental contaminants
(1,2). Within this group the polybrominated
diphenyl ethers (PBDEs) are used in large
quantities as flame-retardant additives in
polymers, especially in the manufacture of a
variety of electrical appliances, including tele-
vision and computer casing, building materi-
als, and textiles (3,4). Because PBDEs are
mixed, not chemically bound, into the mate-
rial they are used in, they may migrate from
the material. One of the earliest reports of
PBDE in our environment came in 1981 (5).
Since then, PBDEs have been shown to be
persistent compounds that appear to have an
environmental dispersion similar to that of
polychlorinated biphenyls (PCBs) and
dichlorodiphenyltrichloroethane (DDT)
(2,6). PBDE has been found in various
wildlife species and in human tissues (1,7).
The PBDE congeners that dominate in envi-
ronmental and human samples are 2,2´,4,4´-
tetrabromodiphenyl ether (PBDE 47) and
2,2´,4,4´,5-pentabromodiphenyl ether
(PBDE 99). These agents together with tetra-
bromo-bis-phenol-A (TBBPA) have also
been detected in human plasma samples
(6,8) and in mother’s milk (9,10). A study on
certain organochlorine and organobromine
contaminants in milk from native Swedish
mothers showed that the concentration of
PBDEs has increased continuously from
1972 to 1997, whereas those of organochlo-
rine compounds such as PCB and DDT have
decreased (9,10). The concentration of
PBDEs in 1997 was still lower than those of
PCBs and DDT. The concentration for
PCBs was 324 ng/g lipid, for DDT 14 ng/g
lipid, and for PBDEs 4 ng/g lipid. However,
of special concern is that the PBDEs show an
exponential increase from 1972 to 1997 with
a rate of increase that doubled in 5-year
increments (9,10).
In mammals, the fetus can be directly
exposed during gestation via maternal intake
of toxic agents. During the neonatal period,
offspring may be contaminated by ingesting
mother’s milk or by direct exposure to xeno-
biotics (11). In many mammalian species a
rapid growth of the brain occurs during peri-
natal development—the so-called brain
growth spurt (12). In humans, this period
begins during the third trimester of preg-
nancy and continues throughout the first 2
years of life. In mouse and rat this period is
neonatal, spanning the first 3–4 weeks of
life, during which the brain undergoes sev-
eral fundamental phases, such as axonal and
dendritic outgrowth and the establishment
of neural connections. During this period,
animals also acquire many new motor and
sensory abilities (13) and their spontaneous
motor behavior peaks (14). The brain
growth spurt is associated with numerous
biochemical changes that transform the feto-
neonatal brain into that of the mature adult
(15,16). One of the major transmitter sys-
tems that undergo rapid development is the
cholinergic system, which is involved in
many behavioral phenomena and cognitive
functions (17,18). 
In several reports we have shown that
low-dose exposure to both persistent and
nonpersistent environmental agents during
the neonatal period disrupts adult brain func-
tion. Among the toxicants that induce such
neurotoxic effects are DDT (19,20),
pyrethroids (20), organophosphate (21),
nicotine (22), paraquat and MPTP (23), and
certain PCBs (24). The induction of behav-
ioral and cholinergic disturbances in the
adult animal has often been limited to a short
period during neonatal development, around
postnatal day 10 (19,21,22). Those studies
also showed that the induction of these dis-
turbances occurs at doses that apparently
have no permanent effect when administered
to the adult animal. Furthermore, the expo-
sure level for nicotine, PCB, and DDT were
also in the same order of magnitude to
which humans can be exposed (20,22,24).
Exposure to PCB, DDT, or nicotine during
this phase of development can also lead to an
increased susceptibility to toxic agents at
adult age, indicating that neonatal exposure
to toxic agents can potentiate and/or modify
the reaction to adult exposure to xenobiotics
(25–27).
In view of an increasing amount of
PBDEs and TBBPA in the environment
and in mother’s milk, we undertook the
present study to investigate possible behav-
ioral effects of PBDEs and TBBPA when
given during the rapid development of the
neonatal mouse brain.
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Articles
Brominated flame retardants are a novel group of global environmental contaminants. Within
this group the polybrominated diphenyl ethers (PBDE) constitute one class of many that are
found in electrical appliances, building materials, and textiles. PBDEs are persistent compounds
that appear to have an environmental dispersion similar to that of polychlorinated biphenyls
(PCBs) and dichlorodiphenyltrichloroethane (DDT). Levels of PBDEs are increasing in mother´s
milk while other organohalogens have decreased in concentration. We studied for developmental
neurotoxic effects two polybrominated diphenylethers, 2,2´,4,4´-tetrabromodiphenyl ether
(PBDE 47) and 2,2´,4,4´,5-pentabromodiphenylether (PBDE 99)—congeners that dominate in
environmental and human samples—together with another frequently used brominated flame
retardant, tetrabromo-bis-phenol-A (TBBPA). The compounds were given to 10-day-old NMRI
male mice, as follows: PBDE 47, 0.7 mg (1.4 µmol), 10.5 mg (21.1 µmol)/kg body weight (bw);
PBDE 99, 0.8 mg (1.4 µmol), 12.0 mg (21.1 µmol)/kg bw; TBBPA, 0.75 mg (1.4 µmol), 11.5
mg (21.1 µmol)/kg bw. Mice serving as controls received 10 mL/kg bw of the 20% fat emulsion
vehicle in the same manner. The present study has shown that neonatal exposure to PBDE 99
and PBDE 47 can cause permanent aberrations in spontaneous behavior, evident in 2- and 4-
month-old animals. This effect together with the habituation capability was more pronounced
with increasing age, and the changes were dose–response related. Furthermore, neonatal exposure
to PBDE 99 also affected learning and memory functions in adult animals. These are develop-
mental defects that have been detected previously in connection with PCBs. Key words: adult,
brominated flame retardants, developmental neurotoxicology, memory and learning, neonatal,
polybrominated diphenyl ethers, spontaneous behavior. Environ Health Perspect
109:903–908(2001). [Online  20 August 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p903-908eriksson/abstract.htmlMaterials and Methods
Animals and Chemicals
We used male NMRI mice to make this
study comparable with our earlier studies,
which were performed on male mice.
Pregnant NMRI mice were purchased from
Charles River, Uppsala, Sweden. Following
parturition, each litter, adjusted within 48 hr
to eight to ten mice by euthanasia of remain-
ing pups, was kept together with its respec-
tive mother in a plastic cage in a room with
an ambient temperature of 22°C and a 12 hr
light:12 hr dark cycle. At an age of 10 days,
pups were exposed to the vehicle or the test
compounds. To keep litters and conditions
standardized and as close to normal as possi-
ble during the neonatal period, we exposed
both sexes. At 4 weeks male mice were
weaned and were placed and raised in groups
of four to seven in a room for male mice
only. The animals were supplied with stan-
dardized pellet food (Lactamin, Stockholm,
Sweden) and tap water ad libitum.
The polybrominated diphenyl ethers
PBDE 47 and PBDE 99 were synthesized at
the Wallenberg Laboratory (28,29),
University of Stockholm, Sweden.
Tetrabromo-bis-phenol-A (TBBPA) was
purchased from Aldrich (Steinheim,
Germany) and was recrystallized from chlo-
roform. The purity of the compounds
exceeded 98%. The substances were dis-
solved in a mixture of egg lecithin (Merck,
Darmstadt, Germany) and peanut oil
(Oleum arachidis) (1:10) and then sonicated
with water to yield a 20% weight:water
(w:w) fat emulsion vehicle containing vari-
ous concentrations of the compounds. The
substances were administered orally, at a vol-
ume of 10 mL/kg body weight (bw), via a
PVC tube (diameter 1.0 mm) as one single
dose on postnatal day 10. The amounts of
the different compounds given were as fol-
lows: 2,2´,4,4´-tetrabromodiphenyl ether
(PBDE 47), 0.7 mg (1.4 µmol), 10.5 mg
(21.1 µmol)/kg bw; 2,2´,4,4´,5-pentabro-
modiphenyl ether (PBDE 99), 0.8 mg (1.4
µmol), 12.0 mg (21.1 µmol)/kg bw; tetra-
bromo-bis-phenol-A (TBBPA), 0.75 mg
(1.4 µmol), 11.5 mg (21.1 µmol)/kg bw.
Mice serving as controls received 10 mL/kg
bw of the 20% fat emulsion vehicle in the
same manner. Each treatment group com-
prised mice from 3–4 different litters.
Behavioral Tests
Spontaneous behavior. We tested sponta-
neous behavior in the male mice at ages 2
and 4 months, as described previously
(19,24). We tested eight mice, randomly
selected from three to four different litters,
once only, and the tests were performed
between 0800 and 1200 hr under the same
ambient light and temperature conditions.
We measured motor activity over 3 ×  20
min in an automated device consisting of
cages (40 ×  25 ×  15 cm) placed within two
series of infrared beams (low level and high
level) (Rat-O-Matic; ADEA Elektronik AB,
Uppsala, Sweden) (30,31). Locomotion was
registered when the mouse moved horizon-
tally through the low-level grid of infrared
beams. For rearing, vertical movement was
registered at a rate of 4 counts per second,
whenever and as long as a single high-level
beam was interrupted—the number of
counts obtained was proportional to time
spent rearing up. To measure total activity, a
pick-up (mounted on a lever with a counter-
weight) with which the test cage was in con-
tact registered all types of vibration within
the test cage, such as mouse movements,
shaking (tremors), and grooming. 
Swim maze. We administered the behav-
ior test to male mice at the age of 5 months.
We tested 16–18 mice, randomly selected
from three to four different litters, for swim
maze performance. The swim maze was of
Morris water maze type (32): a circular gray
tub, 73 cm in diameter, ﬁlled with water at
23°C to a depth of 13 cm from the brim. In
the center of the northwest quadrant of the
pool, a platform was submerged 1 cm beneath
the water surface. The platform was formed
of metal mesh and had a diameter of 12 cm.
We observed the mouse’s ability to locate the
submerged platform for 5 days, the animals
being given ﬁve trials each day between 0900
and 1400 hr. Before the ﬁrst trial each day,
the mouse was placed on the submerged plat-
form for 30 sec. It was then released from the
south position with its head toward the side
of the tub and allowed 30 sec to locate the
platform. If the mouse failed to ﬁnd the plat-
form within 30 sec, it was placed on the plat-
form. After each trial, the mouse remained on
the platform for 30 sec. The mice received
ﬁve trials per day on 4 consecutive days. On
the ﬁfth day the platform was moved to the
center of the northeast quadrant for reversal
trials; otherwise the procedure was the same.
Latency to locate the platform constituted the
total search time of ﬁve trials, maximum 150
sec. Trials 1–20 (days 1–4) measured the
mouse’s spatial learning ability and trials
21–25 (day 5) its relearning ability. The
experimental design of the swim maze test
was the same as used earlier in the experiment
where mice were exposed to the PCBs (24).
Statistical Analysis
Spontaneous behavior. The data were sub-
jected to a split-plot analysis of variance
(ANOVA). Pairwise testing between PBDE
47-, PBDE 99-, TBBPA-, and vehicle-treated
groups was performed with Tukey’s honestly
signiﬁcant difference (HSD) test (33).
Habituation capability. From the spon-
taneous behavior test we calculated a ratio
between the performance period 40–60 min
and 0–20 min for the three different vari-
ables: locomotion, rearing, and total activity.
We used the following calculation: 100
(counts locomotion 40–60 min/counts loco-
motion 0–20 min), 100 (counts rearing
40–60 min/counts rearing 0–20 min), and
100 (counts total activity 40–60 min/counts
total activity 0–20 min). This ratio was used
to analyze alteration in habituation between
2-month-old and 4-month-old mice. These
data were subjected to a split-plot ANOVA. 
Swim maze. The data from day 1 to day
4 were subjected to a split-plot ANOVA.
Pairwise testing between PBDE 47-, PBDE
99-, TBBPA-, and vehicle-treated groups
was performed with Tukey’s HSD test.
Statistical analysis for the behavioral data of
day 5 was submitted to paired t-test (differ-
ence between trial 1 and trial 5) and one-
way ANOVA with pairwise testing between
PBDE 47-, PBDE 99-, TBBPA-, and vehi-
cle-treated groups, using Duncan’s test.
Results
There were no clinical signs of dysfunction
in the treated mice throughout the experi-
mental period, nor were there any signiﬁcant
deviations in body weight gain in the PBDE
47-, PBDE 99-, and TBBPA-treated mice,
compared with the vehicle-treated mice.
Spontaneous Behavior
Figures 1 and 2 show the results from the
spontaneous behavior variables locomotion,
rearing, and total activity in 2- and 4-
month-old NMRI male mice exposed to a
single oral dose of either 1.4 µmol or 21.1
µmol/kg bw of one of the compounds
PBDE 47, PBDE 99, TBBPA, with corre-
sponding controls receiving 10 mL/kg bw of
the 20% fat emulsion vehicle. Two months
after the exposure there were significant
treatment × time interactions [F(12,126) =
12.30 F(12,126 = 13.38, F(12,126) =
10.45], for the locomotion, rearing, and
total activity variables, respectively. Pairwise
testing among PBDE 47, PBDE 99,
TBBPA, and control groups showed a signif-
icant dose-related change in all three test
variables. In control mice there was a distinct
decrease in activity in all behavioral variables
over 60 min. Mice receiving the higher dose
of PBDE 99 (12 mg) or PBDE 47 (10.5 mg)
displayed signiﬁcantly less activity than con-
trols during the first 20-min period (0–20
min), but during the third 20-min period
(40–60 min) they were significantly more
active than the controls. Mice receiving the
lower dose of PBDE 99 (0.8 mg) showed
significantly less rearing and total activity
than controls during the ﬁrst 20-min period
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(40–60 min) these mice were significantly
more active than the controls in the locomo-
tion variable. In mice receiving TBBPA
there were no signiﬁcant change in the vari-
ables locomotion, rearing, and total activity
compared with controls.
Four months after neonatal exposure to
the different brominated flame retardants
there were still signiﬁcant treatment × time
interactions [F(12,126) = 21.41 F(12,126) =
21.09, F(12,126) = 27.12], for the locomo-
tion, rearing, and total activity variables,
respectively (Figure 2). Pairwise testing
among PBDE 47, PBDE 99, TBBPA and
control groups showed a significant dose-
related change in locomotion, rearing, and
total activity. Pairwise testing between
PBDE 99 and control groups showed a sig-
niﬁcant dose-related change in all three test
variables. Mice receiving the lower and the
higher dose of PBDE 99 (0.8 mg or 12 mg)
were significantly less active than controls
during the ﬁrst 20-min period (0–20 min),
but during the last 20-min period (40–60
min) they were significantly more active
than the controls. Mice receiving the higher
dose of PBDE 47 (10.5 mg) displayed signif-
icantly less locomotion, rearing, and total
activity than controls during the ﬁrst 20-min
period (0–20 min), but during the last 20-
min period (40–60 min) they were signifi-
cantly more active than the controls. In mice
receiving TBBPA there were no significant
change in the variables locomotion, rearing,
and total activity compared with controls.
Habituation Capability
By analyzing the habituation ratio between
performance period 40–60 min and 0–20
min, we obtained information about the
ability to habituate to a novel environment
which can be used to analyze changes in
habituation with age. The results from the
habituation ratio, calculated from the spon-
taneous behavior variables locomotion,
rearing, and total activity in 2- and 4-
month-old NMRI male mice are given in
Table 1. The habituation capability was
shown to significantly (p ≤ 0.001) decrease
with age in mice exposed to PBDE 47 [10.5
mg (21.1 µmol)] and PBDE 99 [0.8 mg (1.4
µmol) and 12.0 mg (21.1 µmol)]. In mice
neonatally exposed to TBBPA or the vehicle,
no significant change in habituation ratio
was observed.
Swim Maze Behavior
Mice receiving the higher dose of PBDE 47,
PBDE 99, and TBBPA were tested for swim
maze performance. Figure 3 shows the per-
formance of 5-month-old mice neonatally
exposed to PBDE 47, PBDE 99, TBBPA, or
the vehicle. During the acquisition period of
spatial learning ability, measured from day 1
to day 4, all mice, regardless of treatment,
improved their ability to locate the platform
[F(3,161) = 215.46]. Split-plot ANOVA
revealed no significant treatment × time
interactions among PBDE 47, PBDE 99,
TBBPA, and controls [F(8,161) = 0.54]. On
day 5 the platform was relocated for relearn-
ing by reversal trials. In the ﬁrst trial on day
5, control mice displayed longer latency than
in the last trial on day 4. This is normal
behavior during relearning because, initially,
the mouse searches near the previous plat-
form location (34). However, controls sig-
niﬁcantly improved their ability to ﬁnd the
new location (paired t-test trial 1 vs. trial 5,
p ≤ 0.01), indicating normal relearning in
Articles • Brominated flame retardants: developmental neurotoxicants
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Figure 1. Spontaneous behavior of 2-month-old NMRI male mice exposed at
neonatal day 10 to a single oral dose of PBDE 47, PBDE 99, TBBPA, or the 20%
fat emulsion vehicle. Statistical analyses of behavioral data were done by
ANOVA using a split-plot design (33). Pairwise testing between PBDE- and
TBBPA-exposed and control groups was performed with the Tukey HSD test.
The height of each bar represents the mean ± SD of 8 animals. 
*p < 0.05 and **p < 0.01 compared to control. 
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Figure 2. Spontaneous behavior in 4-month-old NMRI male mice exposed to a
single oral dose of PBDE 47, PBDE 99, TBBPA, or the 20% fat emulsion vehicle
at neonatal day 10. Statistical analyses of behavioral data were done by
ANOVA using a split-plot design (33). Pairwise testing between PBDE- and
TBBPA-exposed and control groups was performed with the Tukey HSD test.
The height of each bar represents the mean ± SD of 8 animals. 
*p < 0.05 and **p < 0.01 compared to control. control animals. In mice receiving the higher
dose of PBDE 99 (12.0 mg) the difference
in latency between trial 1 and trial 5 differed
signiﬁcantly from controls [F(3,57) = 3.42;
Duncan, p ≤ 0.01].
Discussion
Behavior is a major function whereby ani-
mals adapt to changes in the environment.
Changes in behavior may reveal the influ-
ence of chemical pollution on our natural
environment. Spontaneous behavior is espe-
cially meaningful in environmental toxicol-
ogy because it reflects function that is
important for survival of the individual and
for the species in the wild—for example, the
mobility needed to search for food, to mate,
and to elude predators (35).
Our study has shown that neonatal
exposure to PBDE 99 and PBDE 47 can
cause permanent aberrations in spontaneous
behavior. This effect and the habituation
capability appear also to worsen with age.
Furthermore, neonatal exposure to PBDE
99 also affected learning and memory func-
tions in adult animals. Exposure to TBBPA
in the same dose range did not cause any sig-
niﬁcant change in the investigated behavioral
variables. Whether the absence of neurotoxic
effects of TBBPA is related to altered uptake
or metabolism is not known, but TBBPA is
known to have a short half-life (36,37).
The spontaneous motor behavior data
showed a dose–response-related disruption
of habituation in mice treated with both
PBDE 99 and PBDE 47. Habituation—a
decrease in locomotion, rearing, and total
activity variables in response to the dimin-
ishing novelty of the test chamber over 60
min—was demonstrated in the control ani-
mals, but mice treated with PBDE 99 and
PBDE 47 were obviously hypoactive early in
the 60-min test period, whereas toward the
end they became hyperactive. This nonhab-
ituating behavior profile has also been
reported in adult mice neonatally exposed to
ortho-substituted PCBs, such as PCB 28,
PCB 52, PCB 153 (24,38,39), and also in
mice neonatally exposed to coplanar PCBs,
such as PCB 77, PCB 126, and PCB 169
(24,40,41). This indicates that some PBDEs
can be potent inducers of behavioral aberra-
tions and that the changes can be similar to
those observed earlier for some ortho- and
coplanar PCBs. Furthermore, the effects
were induced at doses that did not affect the
animals’ weight gain and at doses compara-
ble to those used in the PCB studies.
The results from the spontaneous behav-
ior tests further indicate that the functional
disorder worsens with increasing age: The
aberrations were more pronounced in 4-
month-old than in 2-month-old mice. In
mice receiving the higher dose of PBDE 99
(12.0 mg/kg bw) the difference, compared
with controls, in the locomotor variable dur-
ing the first 20-min period was about 68%
in 4-month-old mice compared with about
58% in 2-month-old mice, a difference that
was signiﬁcant (t-test, p ≤ 0.01). This time-
dependent effect was evident in mice given
the lower dose (0.8 mg/kg bw) where a signif-
icant decrease in the locomotor variable was
seen in the 4-month-old but not in the 2-
month-old mice. The time-dependent effect
was also evident in this treatment group dur-
ing the last 20-min period, where a signiﬁcant
increase in activity in the rearing and total
activity variables was seen in the 4-month-old
but not in the 2-month-old mice. That this
functional disorder can worsen with age is
supported by the signiﬁcantly reduced habitu-
ation capability in 4-month-old mice com-
pared to 2-month-old mice. Both the change
in spontaneous motor behavior proﬁle, time
dependent and dose related, and the reduced
habituation capability indicate the advance of
brain dysfunction induced at the time of
rapid brain development in the neonatal
mouse. Significantly, neonatal exposure to
certain ortho-substituted and coplanar PCBs
can cause this change in spontaneous motor
behavior profile, both time dependent and
dose related (24,41).
In the present study, the ability of adult
mice to learn and memorize was observed in
a swim maze of the Morris water-maze type.
This maze revealed that mice exposed to the
higher dose of PBDE 99 (12 mg/kg bw) per-
formed signiﬁcantly worse than control ani-
mals. The swim maze allowed a 4-day
acquisition period followed by reversal trials
on the 5th day, when the platform was
moved. In control mice and in mice given
PBDE 99, PBDE 47, and TBBPA, latency
to locate the platform decreased during the
acquisition training, and all tested animals
performed equally well at the end of the
acquisition period. In the reversal trials on
the ﬁfth day, however, mice exposed to the
higher dose of PBDE 99 did not improve in
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Table 1. Habituation capability in 2-month-old and 4-month-old NMRI male mice exposed neonatally to
PBDE 47, PBDE 99, or TBBPAa.
Habituation ratio (age)
Treatment 2-Month-old 4-Month-old F-Value p-Value
Locomotion
Control 1.34 ± 1.45 1.45 ± 1.92 0.02 NS
PBDE 47 l 0.55 ± 0.90 0.91 ± 1.41 0.48 NS
PBDE 47 h 41.6 ± 3.57 69.5 ± 11.2 56.5 0.001
PBDE 99 l 16.6 ± 9.61 39.6 ± 6.08 40.9 0.001
PBDE 99 h 113 ± 11.6 185 ± 48.3 20.7 0.001
TBBPA l 2.15 ± 2.43 1.58 ± 1.86 0.35 NS
TBBPA h 1.43 ± 1.62 3.93 ± 4.87 2.36 NS
Rearing
Control 0.31 ± 0.52 0.27 ± 0.47 0.02 NS
PBDE 47 l 0.00 ± 0.00 0.10 ± 0.32 1.00 NS
PBDE 47 h 75.2 ± 24.5 152 ± 51.1 18.6 0.001
PBDE 99 l 8.89 ± 4.59 44.7 ± 10.1 104 0.001
PBDE 99 h 157 ± 26.7 222 ± 28.2 21.0 0.001
TBBPA l 0.17 ± 0.36 0.36 ± 0.58 0.82 NS
TBBPA h 0.35 ± 0.57 0.33 ± 0.35 0.01 NS
Total activity
Control 11.7 ± 2.14 13.1 ± 2.86 1.53 NS
PBDE 47 l 15.9 ± 2.14 16.2 ± 4.25 0.05 NS
PBDE 47 h 50.6 ± 7.35 79.7 ± 11.7 44.8 0.001
PBDE 99 l 31.2 ± 2.03 61.1 ± 1.86 1,181 0.001
PBDE 99 h 101 ± 7.36 138 ± 14.4 51.3 0.001
TBBPA l 15.7 ± 2.66 15.6 ± 1.77 0.01 NS
TBBPA h 15.2 ± 2.58 17.3 ± 2.40 3.41 NS
Abbreviations: h, high; l, low; NS, not signiﬁcant.
aHabituation capability is the ratio between performance in spontaneous motor behavior period 40–60 min and 0–20 min in
2-month-old and 4-month-old NMRI male mice exposed to a single oral dose of either PBDE 47, l = 1.4 µmol and h = 21.1
µmol/kg bw; PBDE 99, l = 1.4 µmol and h = 21.1 µmol/kg bw; TBBPA, l = 1.4 µmol and h = 21.1 µmol/kg bw; or 20% fat emul-
sion vehicle at neonatal day 10. Statistical analyses of behavioral data were done by ANOVA using a split-plot design (33).
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Figure 3. Swim-maze performance of 5-month-old
NMRI male mice exposed to a single oral dose of
PBDE 47, PBDE 99, TBBPA, or the 20% fat emul-
sion vehicle at neonatal day 10. Latencies to
reach the platform were measured during acqui-
sition (days 1–4) and during reversal trials (day 5).
Behavioral data, days 1–4, were analyzed by
ANOVA using a split-plot design (33). Statistical
analyses of behavioral data for day 5 were done
by paired t-test and ANOVA 1-way combined with
Duncan’s test. Each point represents the mean of
16–18 animals.ﬁnding the new location of the platform, an
improvement that was seen in control mice
and mice exposed to PBDE 47 and TBBPA. 
The maze learning/memory test and the
spontaneous behavior test reveal that PBDE
99 is more potent in causing neurotoxic
effects than PBDE 47. This indicates differ-
ences in neurotxicity among different PBDE
congeners—changes such as those seen earlier
for different PCB congeners. In previous
studies we observed altered new/reversal
learning in swim-maze performance in adult
mice neonatally exposed to PCB 52 (38) and
PCB 126 (41) but not after neonatal exposure
to PCB 28 (38). Furthermore, in animals
showing defects in new/reversal learning, the
nicotinic receptors in the brain were affected.
The behavioral performance in tasks requiring
attention and rapid processing of information
in humans and new/reversal learning and
working memory in animals may involve
cholinergic transmission (42), and the cholin-
ergic system is one of the major transmitter
systems that correlate closely with cognitive
function (43,44). Whether neonatal exposure
to PBDEs can affect cholinergic receptors in
the brain is therefore of special interest and
calls for further studies, because in neurode-
generative diseases, such as Alzheimer and
Parkinson, there is a change in cholinergic
nicotinic receptors in the cerebral cortex and
hippocampus (45,46). 
Do we have a novel class of developmen-
tal neurotoxicants in our environment? It is
particularly worth noting that neonatal
exposure to PBDE 99, and to a lesser degree
PBDE 47, affected spontaneous behavior,
habituation capability, and learning and
memory in adult mice, similar to those
observed earlier for PCBs. That different
PBDE congeners can have different potency
in causing neurotoxic effects is important
when comparing the levels of PBDEs in the
environment and in mother’s milk, but also
when comparing levels of PBDEs to the lev-
els of certain PCBs. In our earlier studies we
have seen that the amount of ortho-substi-
tuted PCB congeners, such as PCB 52 and
PCB 153, found in the brain 24 hr after a
single oral administration to 10-day-old
mice is about 3–5 per mille of the adminis-
tered dose (24). Data on actual tissue levels
of PCBs in infants are few. The amounts of
these different PCBs given in our studies
resulted in a brain tissue concentration (ppb
levels) that can be of the same order of mag-
nitude observed in infants less than 1 year of
age (47). 
In human studies it is difﬁcult to distin-
guish between exposure of offspring by
transplacental or by breast milk transfer.
However, both human and animal data from
a variety of species suggest that accumulation
of highly persistent chemicals ingested via
milk far exceeds the contribution made by
maternal–fetal transfer (47). Although the
total amount of PCB in mother’s milk is
higher than that of PBDE, it is important to
compare the levels of single congeners. The
concentration of PBDEs found in native
Swedish mother’s milk was 4 ng/g lipid in
1997 (9,10). The amount of PBDE 47 was
2.3 ng/g lipid and PBDE 99 0.5 ng/g lipid.
The levels of PCB 52 in Swedish mother’s
milk was 1 ng/g lipid in 1996 and for PCB
153 73 ng/g lipid in 1997 (9,10). From the
same study (9) it is also worth noting that
the amount of DDT, a well known neuro-
toxic compound, was about 6 times higher
than PBDE 47—14 ng/g lipid. Human epi-
demiologic studies suggest that perinatal
exposure to PCBs can have developmental
neurotoxic effects (48–51). Experimental
studies in animals have shown that commer-
cial mixtures of PCBs can cause behavioral
aberrations and changes in brain neurotrans-
mitter metabolism (52–54). Exposure of
mice, rats, and monkeys to commercial mix-
tures of PCBs during development can pro-
duce long-term neurobehavioral changes
(55,56). Recently, Rice and Hayward (57)
have shown cognitive defects in adult mon-
keys exposed postnatally, from birth to 20
weeks of age, to a PCB mixture representa-
tive of the PCB congeners typically found in
human breast milk. In our animal model we
have seen that certain PCB congeners,
known to be present in the environment and
human milk, given during a critical phase of
neonatal development, when the maturation
of the developing brain and CNS is at a
stage of critical vulnerability, induce persis-
tent neurotoxic effects (24). In these studies,
the lowest dose of the PCB congeners, PCB
52 and PCB 153, shown to induce develop-
mental neurotoxic effects is the same as the
one used in the present study of PBDE 99—
1.4 µmol/kg bw.
Our present ﬁndings that developmental
exposure to PBDE can cause similarities in
behavioral disturbances as seen earlier for
PCBs is of special interest, not only for
PBDE as a single agent but for possible
interactive effects between these persistent
environmental agents and the present back-
ground levels of PCBs. Given the increasing
concentration of PBDEs in mother’s milk,
we call for future research into PBDEs as
potential neurotoxicants.
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